Isolation, culturing and characterization of rat adipose tissue-derived mesenchymal stem cells: a simple technique

In this study, our aim was to develop a new simple technique for isolation of mesenchymal stem cells from adipose tissue. For this purpose, mesenchymal stem cells were isolated from rat adipose tissue by using the primary explant culture technique. When the cells became confluent, they were passaged 4 times by using the standard trypsinization method with trypsin/EDTA solution. Cells at second passage were characterized by using immunofluorescence staining against CD13 and CD29 markers. The results showed that these cultured cells were positive for CD13 and CD29 markers. Flow cytometry analysis was also done against CD29, CD90, CD54, MHC Class I, CD45, CD106, and MHC Class II for characterization of mesenchymal stem cells. The results of flow cytometry analysis showed that these cells were mesenchymal stem cells. Half of the cells were cryopreserved at all passages for future applications. It is thought that these mesenchymal stem cells can be used in therapy of cardiovascular diseases as an alternative technique in the near future.

[1]  Erik Jørgensen,et al.  Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design. , 2012, Regenerative medicine.

[2]  D. Hutmacher,et al.  CD73 and CD29 concurrently mediate the mechanically induced decrease of migratory capacity of mesenchymal stromal cells. , 2011, European cells & materials.

[3]  S. Böhm,et al.  Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC , 2011, Cell Communication and Signaling.

[4]  S. Kang,et al.  Effects of Expanded Human Adipose Tissue-Derived Mesenchymal Stem Cells on the Viability of Cryopreserved Fat Grafts in the Nude Mouse , 2011, International journal of medical sciences.

[5]  Nan Ma,et al.  Cell Origin of Human Mesenchymal Stem Cells Determines a Different Healing Performance in Cardiac Regeneration , 2011, PloS one.

[6]  N. Arslan,et al.  In vitro effect of resveratrol against oxidative injury of human coronary artery endothelial cells , 2011, Turkish Journal of Medical Sciences.

[7]  Y. Öztaş,et al.  Plasma LDL subtype distribution in patients with or without coronary stenosis , 2011, Turkish Journal of Medical Sciences.

[8]  Yan Li,et al.  High efficient isolation and systematic identification of human adipose-derived mesenchymal stem cells , 2011, Journal of Biomedical Science.

[9]  R. Jérôme,et al.  Culture and Use of Mesenchymal Stromal Cells in Phase I and II Clinical Trials , 2010, Stem cells international.

[10]  Andrea Augello,et al.  Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. , 2010, European cells & materials.

[11]  Patrick C Sachs,et al.  Isolating adipose-derived mesenchymal stem cells from lipoaspirate blood and saline fraction , 2010, Organogenesis.

[12]  G. Perigli,et al.  Characterization of human adult stem‐cell populations isolated from visceral and subcutaneous adipose tissue , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  M. Joglekar,et al.  Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. , 2009, Cytotherapy.

[14]  Manuel A. González,et al.  Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. , 2009, Gastroenterology.

[15]  P. Menasché,et al.  Handbook of Cardiac Stem Cell Therapy , 2008 .

[16]  Mohamed H. Sayegh,et al.  Immunomodulation by Mesenchymal Stem Cells , 2008, Diabetes.

[17]  Bindiya Patel,et al.  Adipose-derived stem cells: isolation, expansion and differentiation. , 2008, Methods.

[18]  P. Bianco,et al.  Mesenchymal stem cells: revisiting history, concepts, and assays. , 2008, Cell stem cell.

[19]  Mohamed H. Sayegh,et al.  Immunomodulation by Mesenchymal Stem Cells , 2008, Diabetes.

[20]  A. Luttun,et al.  Emerging hurdles in stem cell therapy for peripheral vascular disease , 2008, Journal of Molecular Medicine.

[21]  Qingbo Xu,et al.  Stem cell therapy for vascular disease. , 2007, Trends in cardiovascular medicine.

[22]  H. Wiesmann,et al.  Decreased CD90 expression in human mesenchymal stem cells by applying mechanical stimulation , 2006, Head & face medicine.

[23]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[24]  M. Hedrick,et al.  Multipotential differentiation of adipose tissue-derived stem cells. , 2005, The Keio journal of medicine.

[25]  Q. Han,et al.  Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. , 2005, Biochemical and biophysical research communications.

[26]  Sunil S Tholpady,et al.  Cell Surface and Transcriptional Characterization of Human Adipose‐Derived Adherent Stromal (hADAS) Cells , 2005, Stem cells.

[27]  Daniel A. De Ugarte,et al.  Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. , 2003, Immunology letters.

[28]  E. Sim,et al.  Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. , 2003, The Annals of thoracic surgery.

[29]  F. Guilak,et al.  Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. , 2003, Cytotherapy.

[30]  Min Zhu,et al.  Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.

[31]  D. Hutmacher,et al.  CD 73 AND CD 29 CONCURRENTLY MEDIATE THE MECHANICALLY INDUCED DECREASE OF MIGRATORY CAPACITY OF MESENCHYMAL STROMAL CELLS , 2022 .